These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17978809)

  • 21. Antimicrobial activity of topical agents against Propionibacterium acnes: an in vitro study of clinical isolates from a hospital in Shanghai, China.
    Ma Y; Zhang N; Wu S; Huang H; Cao Y
    Front Med; 2016 Dec; 10(4):517-521. PubMed ID: 27896620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes.
    Gans EH; Kligman AM
    J Dermatolog Treat; 2002 Sep; 13(3):107-10. PubMed ID: 12227872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro.
    Unkles SE; Gemmell CG
    Antimicrob Agents Chemother; 1982 Jan; 21(1):39-43. PubMed ID: 7081974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of antibiotic resistance in Propionibacterium acnes.
    Leyden J; Levy S
    Cutis; 2001 Feb; 67(2 Suppl):21-4. PubMed ID: 11236211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
    Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
    Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
    Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K
    Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris.
    Ishida N; Nakaminami H; Noguchi N; Kurokawa I; Nishijima S; Sasatsu M
    Microbiol Immunol; 2008 Dec; 52(12):621-4. PubMed ID: 19120976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
    Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y
    J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bacterial resistance in acne? A meta-analysis of the controversy].
    Alvarez-Sánchez M; Rodríguez-Ayala E; Ponce-Olivera RM; Tirado-Sánchez A; Arellano-Mendoza MI
    Cir Cir; 2016; 84(3):190-5. PubMed ID: 26738649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes.
    Oprica C; Nord CE;
    Clin Microbiol Infect; 2005 Mar; 11(3):204-13. PubMed ID: 15715718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I; Nishijima S; Kawabata S
    Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes.
    Crawford WW; Crawford IP; Stoughton RB; Cornell RC
    J Invest Dermatol; 1979 Apr; 72(4):187-90. PubMed ID: 429800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial resistance in French acne patients.
    Dumont-Wallon G; Moyse D; Blouin E; Dréno B
    Int J Dermatol; 2010 Mar; 49(3):283-8. PubMed ID: 20465665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore.
    Tan HH; Goh CL; Yeo MG; Tan ML
    Ann Acad Med Singap; 2001 Jan; 30(1):22-5. PubMed ID: 11242619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antibacterial activity of NB-003 against Propionibacterium acnes.
    Pannu J; McCarthy A; Martin A; Hamouda T; Ciotti S; Ma L; Sutcliffe J; Baker JR
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4211-7. PubMed ID: 21746943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic susceptibility of
    Zhu T; Zhu W; Wang Q; He L; Wu W; Liu J; Li Y; Sun D
    BMJ Open; 2019 Feb; 9(2):e022938. PubMed ID: 30782869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D
    MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325
    [No Abstract]   [Full Text] [Related]  

  • 38. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
    Gübelin W; Martínez MA; Molina MT; Zapata S; Valenzuela ME
    Rev Latinoam Microbiol; 2006; 48(1):14-6. PubMed ID: 17357569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%.
    Leyden JJ; Wortzman M; Baldwin EK
    Cutis; 2008 Dec; 82(6):417-21. PubMed ID: 19181031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of topical erythromycin on aerobic and anaerobic surface flora.
    Bernstein JE; Shalita AR
    Acta Derm Venereol; 1980; 60(6):537-9. PubMed ID: 6162344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.